LTX by Broadridge Launches BondGPT Powered by OpenAI GPT-4 - Yahoo Finance
BIIB34 Stock | BRL 152.70 2.54 1.69% |
About 52% of Biogen's investors are presently thinking to get in. The analysis of current outlook of investing in Biogen Inc suggests that some traders are interested regarding Biogen's prospects. The current market sentiment, together with Biogen's historical and current headlines, can help investors time the market. In addition, many technical investors use Biogen Inc stock news signals to limit their universe of possible portfolio assets.
Biogen |
LTX by Broadridge Launches BondGPT Powered by OpenAI GPT-4 Yahoo Finance
Read at news.google.com
Biogen Fundamental Analysis
We analyze Biogen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biogen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
Biogen is rated third in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Biogen Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biogen stock to make a market-neutral strategy. Peer analysis of Biogen could also be used in its relative valuation, which is a method of valuing Biogen by comparing valuation metrics with similar companies.
Peers
Biogen Related Equities
ABBV34 | AbbVie | 3.79 | ||||
BMYB34 | Bristol Myers | 3.63 | ||||
MRCK34 | Merck | 3.41 | ||||
BIIB34 | Biogen | 1.69 | ||||
GILD34 | Gilead Sciences | 1.58 |
Complementary Tools for Biogen Stock analysis
When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |